Comparison of developing tuberculosis following tumor necrosis factor inhibition and interleukin-6 inhibition in patients with rheumatoid arthritis: a nationwide observational study in South Korea, 2013-2018.

Seung-Min JungMinkyung HanEun Hwa KimInkyung JungYong-Beom Park

Published in: Arthritis research & therapy (2022)

The incidence of TB was not significantly different among biologic drugs in the current era, except for infliximab in patients who were not treated for LTBI. Treatment of LTBI might alleviate the drug-specific risk of TB in patients with RA.

Keyphrases

mycobacterium tuberculosis
rheumatoid arthritis
risk factors
disease activity
pulmonary tuberculosis
adverse drug
drug induced
ankylosing spondylitis
cross sectional
hiv aids
newly diagnosed